Markets:

Overview

News

Currencies

International

Treasuries

Churchill Capital Corp XI - Class A Ordinary Shares (NQ:CCXI)

10.19 -0.05 (-0.49%)

Streaming Delayed Price Updated: 3:07 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Churchill Capital Corp XI - Class A Ordinary Shares

< Previous 1 2 3 4 5 6 Next >

Recap: ChemoCentryx Q4 Earnings ↗

March 01, 2022

ChemoCentryx (NASDAQ:CCXI) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution ↗

March 01, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Editas Gains On Resolution Of CRISPR Gene Editing Patent Case Editas Medicine...

Via Benzinga

Earnings Scheduled For March 1, 2022 ↗

March 01, 2022

Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...

Via Benzinga

Earnings Preview: ChemoCentryx ↗

February 28, 2022

ChemoCentryx (NASDAQ:CCXI) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight ↗

February 27, 2022

Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first...

Via Benzinga

Is Now The Time To Buy Stock In ChemoCentryx, Ideanomics Or Snowflake? ↗

February 25, 2022

Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings b...

Via Benzinga

Why ChemoCentryx Shares Are Rising ↗

January 19, 2022

ChemoCentryx Inc (NASDAQ:CCXI) shares are trading higher a...

Via Benzinga

ChemoCentryx's Avacopan Scores European Approval For ANCA-Associated Vasculitis ↗

January 19, 2022

The European Union has approved ChemoCentryx Inc's (NASDAQ: CCXI) Tavneos (avacopan) for ANCA-associated vasculitis. The approval follows the FDA approval of...

Via Benzinga

Expert Ratings For ChemoCentryx ↗

November 10, 2021

Analysts have provided the following ratings for ChemoCentryx (NASDAQ:CCXI...

Via Benzinga

ChemoCentryx, inc (CCXI) Q3 2021 Earnings Call Transcript ↗

November 10, 2021

CCXI earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates ↗

November 02, 2021

The loaded Prescription Drug User Fee Act (PDUFA) calendar for October produced mixed outcomes. PDUFA dates are key binary events for biotech stocks that can move the needle in a...

Via Benzinga

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗

November 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...

Via Benzinga

Is It Too Late to Buy ChemoCentryx Stock? ↗

October 14, 2021

The stock surged after obtaining FDA approval for avacopan.

Via The Motley Fool

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗

November 08, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...

Via Benzinga

2 Super-Charged Growth Stocks to Buy Now ↗

October 13, 2021

These two small drugmakers are poised for a long-winded growth spurt.

Via The Motley Fool

45 Biggest Movers From Yesterday ↗

October 13, 2021

Gainers ESSTech Inc (NYSE: GWH) shares surged 128.4% to close at $23.80 onTuesday. ESS Inc, the Bill Gates-backed battery maker went public on the NewYork Stock Exchange on...

Via Benzinga

BZ Chart Of The Day: ChemoCentryx ↗

October 11, 2021

There’s an old saying on Wall Street that "gaps refill." It's true and it may be about to happen to shares of ChemoCent...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2021 ↗

October 11, 2021

Upgrades According to Vertical Research, the prior rating for C.H. Robinson Worldwide Inc (NASDAQ:

Via Benzinga

Thinking About Buying Stock In Starbucks, Peloton Or ChemoCentryx? ↗

October 11, 2021

One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why Is It Moving, or WIIM, feature in...

Via Benzinga

Futures Slide As Soaring Oil Nears $85 ↗

October 11, 2021

While cash bonds may be closed, one can easily extrapolate where they would be trading based on TSY futures which are currently trading at a 1.65% equivalent.

Via Talk Markets

Topics Bonds

10 Biggest Price Target Changes For Monday ↗

October 11, 2021

Keybanc lifted Netflix, Inc. (NASDAQ: NFLX) price target from $645 to $670. Netflix shares rose 0.1% to $633.00 in pre-market trading. JMP Securities raised ServiceNow, Inc. (...

Via Benzinga

A Peek Into The Markets: US Stock Futures Down; Crude Oil Jumps 2% ↗

October 11, 2021

Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Nasdaq dropped around 75 points in the previous session. Futures for the Dow Jones Industrial...

Via Benzinga

Topics Stocks

35 Biggest Movers From Friday ↗

October 11, 2021

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares surged 96% to close at $38.41 on Friday. The FDA approved ChemoCentryx’s Tavneos (avacopan) as an adjunctive treatment for...

Via Benzinga

5 Stocks To Watch For October 11, 2021 ↗

October 11, 2021

Some of the stocks that may grab investor focus today are: Mandiant Inc (NASDAQ: MNDT) reported the completion of divestiture of its FireEye Products unit to McAfee Enterprise...

Via Benzinga

The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage ↗

October 10, 2021

Biotech stocks retreated in the week ending Oct. 8, extending losses for the third straight week. Some of the selling in the space was due to money moving out of defensive stocks and into risky bets...

Via Talk Markets

The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage ↗

October 10, 2021

Biotech stocks retreated in the week ending Oct. 8, extending losses for the third straight week. Some of the selling in the space was due to money moving out of defensive...

Via Benzinga

Why ChemoCentryx Stock Skyrocketed Today ↗

October 08, 2021

Investors are excited about the biotech's game-changing new drug.

Via The Motley Fool

Mid-Afternoon Market Update: Dow Surges 80 Points; ChemoCentryx Shares Spike Higher ↗

October 08, 2021

Toward the end of trading Friday, the Dow traded up 0.24% to 34,835.06 while the NASDAQ fell 0.13% to 14,635.04. The S&P also rose, gaining 0.13% to 4,405.69. The U.S. has the...

Via Benzinga

Topics Stocks

ChemoCentryx, Allogene Show the Risks and Rewards of Nasdaq Biotech Stocks ↗

October 08, 2021

The broader market was mixed on Friday.

Via The Motley Fool

Topics Stocks

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 08, 2021

Gainers ChemoCentryx (NASDAQ:CCXI) stock increased by 70.43% to $33.41 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 74.6...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Churchill Capital Corp XI - Class A Ordinary Shares (NQ:CCXI)

Headline News about Churchill Capital Corp XI - Class A Ordinary Shares

Starting at $3.75/week.

Subscribe Today